The above data argues that the physiological changes observed in Mpzl3 ASO treated mice were driven by cumulative tissue‐specific changes in lipid metabolism resulting in an overall protection from diet‐induced obesity. The gene discussed is MPZL3; the disease is obesity due to melanocortin 4 receptor deficiency.